Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

Detalles Bibliográficos
Autores principales: Serrano, César, Mariño-Enríquez, Adrián, Tao, Derrick L., Ketzer, Julia, Eilers, Grant, Zhu, Meijun, Yu, Channing, Mannan, Aristotle M., Rubin, Brian P., Demetri, George D., Raut, Chandrajit P., Presnell, Ajia, McKinley, Arin, Heinrich, Michael C., Czaplinski, Jeffrey T., Sicinska, Ewa, Bauer, Sebastian, George, Suzanne, Fletcher, Jonathan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738067/
https://www.ncbi.nlm.nih.gov/pubmed/31123346
http://dx.doi.org/10.1038/s41416-019-0487-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738067/
https://www.ncbi.nlm.nih.gov/pubmed/31123346
http://dx.doi.org/10.1038/s41416-019-0487-5

Ejemplares similares